Quick Answer
Bioquest Corp reported Stockholders Equity of -$433.0 thousand for the year ending 2022.
- Bioquest Corp showed an increase of +75.5% in Stockholders Equity from 2021 to 2022.
- This data is from Bioquest Corp's annual report (Form 10-K), filed with the SEC on August 15, 2022.
- XBRL data for this metric is available from 2012 to 2022 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2013: $4.0 thousand | Q2 2014: $875.2 thousand | Q3 2014: $4.77 million | Q4 2014: $4.63 million | Q1 2015: $5.08 million | Q4 2019: -$11.7 thousand | Q1 2020: -$6.7 thousand | Q3 2020: -$360.8 thousand | Q4 2020: -$803.1 thousand | Q1 2021: -$1.45 million | Q2 2021: -$1.77 million | Q3 2021: -$2.14 million | Q4 2021: -$443.7 thousand | Q1 2022: -$393.6 thousand | Q2 2022: -$433.0 thousand | Q3 2022: -$536.4 thousand.
- Over the full 7 years of available data (2012 to 2022), Bioquest Corp's Stockholders Equity has declined by 15,902.6%.
- Historical annual values: Fiscal year 2022: -$433.0 thousand | Fiscal year 2021: -$1.77 million | Fiscal year 2020: -$138.6 thousand | Fiscal year 2019: -$8.8 thousand | Fiscal year 2014: $875.2 thousand | Fiscal year 2013: $9.0 thousand | Fiscal year 2012: $2.7 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: